You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Microsatellite instability

Showing 1 - 25 of 1,595
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Trial in Kashiwa (HRO761,

Recruiting
  • MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
  • Kashiwa, Chiba, Japan
    Novartis Investigative Site
May 2, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Advanced Solid Tumors Trial (RO7589831)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Aug 16, 2023

Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

Not yet recruiting
  • Melanoma
  • +5 more
  • INCB 99280 with Ipilimumab
  • (no location specified)
Jun 9, 2023

Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

Active, not recruiting
Has Results
  • Colorectal Carcinoma
  • (no location specified)
Oct 28, 2022

Colorectal Cancer Trial in Beijing (IBI310 (anti-CTLA-4 antibody), Sintilimab(anti-PD-1 antibody))

Active, not recruiting
  • Colorectal Cancer
  • IBI310 (anti-CTLA-4 antibody)
  • Sintilimab(anti-PD-1 antibody)
  • Beijing, China
    Beijing cancer hospital
Sep 15, 2022

Adenocarcinoma - GEJ, Gastric Adenocarcinoma Trial (Dostarlimab)

Not yet recruiting
  • Adenocarcinoma - GEJ
  • Gastric Adenocarcinoma
  • (no location specified)
Sep 26, 2023

Colorectal Cancers With Microsatellite Instability

Active, not recruiting
  • Colorectal Cancer
  • Microsatellite Instability
    • Poitiers, Vienne, France
    • +13 more
    Aug 19, 2022

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Digestive System Cancers Trial in Beijing (KN046, Regorafenib, Apatinib)

    Recruiting
    • Digestive System Cancers
    • Beijing, China
      Peking University Cancer Hospital
    Oct 25, 2023

    Registry Study in MSI/dMMR Solid Tumors

    Not yet recruiting
    • DMMR Cancer
    • +2 more
      • (no location specified)
      Aug 21, 2023

      Gastric Cancer, Microsatellite Instability Trial in Milan (Durvalumab, Tremelimumab)

      Recruiting
      • Gastric Cancer
      • Microsatellite Instability
      • Milan, Italy
        Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
      Aug 3, 2022

      Recurrent/Metastatic Gastric Cancer Trial in Seoul (Nivolumab, Paclitaxel)

      Completed
      • Recurrent/Metastatic Gastric Cancer
      • Nivolumab, Paclitaxel
      • Seoul, Korea, Republic of
        Yonsei University Health System, Severance Hospital
      Sep 9, 2022

      Microsatellite Instability in Colorectal Cancers

      Completed
      • Colorectal Cancer
      • +4 more
      • Microsatellite instability analysis
      • Istanbul, Turkey
        Sultan 2. Abdulhamid Training and Research Hospital
      Dec 5, 2021

      Colorectal Cancer Stage IV, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial (Cadonilimab)

      Not yet recruiting
      • Colorectal Cancer Stage IV
      • +2 more
      • (no location specified)
      Jun 19, 2022

      Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

      Recruiting
      • Non Small Cell Lung Cancer
      • +10 more
      • Los Angeles, California
      • +4 more
      Sep 5, 2023

      Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

      Recruiting
      • Neoadjuvant Chemoradiation Therapy
      • +3 more
      • xintilimab injection
      • Control
      • Shanghai, Shanghai, China
        Department of Colorectal Surgery in Changhai Hospital
      Aug 5, 2022

      Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

      Recruiting
      • Colorectal Neoplasms
      • Microsatellite Instability
      • temozolomide (induction),
      • pembrolizumab (treatment)
      • Milano, Italy
      • +3 more
      Sep 28, 2022

      DOstarlimab in Recurrent or dMMR/MSI-H Endometrial Cancer

      Not yet recruiting
      • Endometrial Cancer
      • (no location specified)
      Feb 14, 2023

      Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in Guangzhou (Neoadjuvant

      Recruiting
      • Colorectal Cancer
      • +3 more
      • Neoadjuvant therapy with PD-L1 inhibitor
      • Guangzhou, Guangdong, China
        the Third Affiliated Hospital of Sun Yat-Sen University
      May 10, 2022

      POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

      Terminated
      • POLE Exonuclease Mutant Colon Cancer
      • +2 more
      • Sutton, Surrey, United Kingdom
        Royal Marsden NHS Foundation Trust
      Oct 5, 2022

      High-Frequency Microsatellite Instability, Mismatch Repair Gene Mutation, Mutation-Negative Lynch Syndrome Trial in Houston

      Active, not recruiting
      • High-Frequency Microsatellite Instability
      • +3 more
      • Exercise Intervention
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 11, 2022

      Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

      Recruiting
      • Gastric Cancer
      • +9 more
      • Tumor Infiltrating Lymphocytes (TIL)
      • Fludarabine + Cyclophosphamide combination
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 21, 2022

      Multiple Cancer, Colorectal Cancer Trial (MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 mAb neoadjuvant

      Not yet recruiting
      • Multiple Cancer
      • Colorectal Cancer
      • MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy
      • All-MSI-H (dMMR) sMPCC: single-drug PD-1 monoclonal antibody neoadjuvant therapy
      • (no location specified)
      Aug 20, 2023

      Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

      Recruiting
      • Advanced or Metastatic Solid Tumors
      • +11 more
      • Tucson, Arizona
      • +11 more
      Dec 2, 2022